Albrecht J - Search Results

1

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus.

Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, Kantor J, Kim E, Militello G, McGinnis K, Richardson S, Treat J, Vittorio C, Van Voorhees A, Werth VP. Albrecht J, et al. J Invest Dermatol. 2005 Nov;125(5):889-94. doi: 10.1111/j.0022-202X.2005.23889.x. J Invest Dermatol. 2005. PMID: 16297185 Free PMC article.

2

Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus.

Albrecht J, Berlin JA, Braverman IM, Callen JP, Connolly MK, Costner MI, Dutz J, Fivenson D, Franks AG, Jorizzo JL, Lee LA, McCauliffe DP, Sontheimer RD, Werth VP. Albrecht J, et al. Lupus. 2004;13(11):839-49. doi: 10.1191/0961203304lu2020oa. Lupus. 2004. PMID: 15580979

3

Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.

Heaphy MR, Albrecht J, Werth VP. Heaphy MR, et al. Among authors: albrecht j. Arch Dermatol. 2005 Jun;141(6):699-702. doi: 10.1001/archderm.141.6.699. Arch Dermatol. 2005. PMID: 15967915

4

Cross-sectional study of bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapy.

Liu RH, Albrecht J, Werth VP. Liu RH, et al. Among authors: albrecht j. Arch Dermatol. 2006 Jan;142(1):37-41. doi: 10.1001/archderm.142.1.37. Arch Dermatol. 2006. PMID: 16415384

5

Skin involvement and outcome measures in systemic autoimmune diseases.

Albrecht J, Atzeni F, Baldini C, Bombardieri S, Dalakas MC, Demirkesen C, Yazici H, Mat C, Werth VP, Sarzi-Puttini P. Albrecht J, et al. Clin Exp Rheumatol. 2006 Jan-Feb;24(1 Suppl 40):S52-9. Clin Exp Rheumatol. 2006. PMID: 16466625 Review.

6

Development of the CLASI as an outcome instrument for cutaneous lupus erythematosus.

Albrecht J, Werth VP. Albrecht J, et al. Dermatol Ther. 2007 Mar-Apr;20(2):93-101. doi: 10.1111/j.1529-8019.2007.00117.x. Dermatol Ther. 2007. PMID: 17537137

7

Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.

Werth VP, Fivenson D, Pandya AG, Chen D, Rico MJ, Albrecht J, Jacobus D. Werth VP, et al. Among authors: albrecht j. Arch Dermatol. 2008 Jan;144(1):25-32. doi: 10.1001/archderm.144.1.25. Arch Dermatol. 2008. PMID: 18209165 Free PMC article. Clinical Trial.

8

The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.

Bonilla-Martinez ZL, Albrecht J, Troxel AB, Taylor L, Okawa J, Dulay S, Werth VP. Bonilla-Martinez ZL, et al. Among authors: albrecht j. Arch Dermatol. 2008 Feb;144(2):173-80. doi: 10.1001/archderm.144.2.173. Arch Dermatol. 2008. PMID: 18283174 Free PMC article.

9

The cutaneous lupus disease activity and severity index as a validated outcome measure for cutaneous lupus erythematosus: comment on the article by Stamm et al.

Krathen M, Albrecht J, Werth VP. Krathen M, et al. Among authors: albrecht j. Arthritis Rheum. 2008 Apr 15;59(4):601-2. doi: 10.1002/art.23544. Arthritis Rheum. 2008. PMID: 18383405 Free PMC article. No abstract available.

10

Quality of life and disease severity in a cutaneous lupus erythematosus pilot study.

Gaines E, Bonilla-Martinez Z, Albrecht J, Taylor L, Okawa J, Troxel AB, Werth VP. Gaines E, et al. Among authors: albrecht j. Arch Dermatol. 2008 Aug;144(8):1061-2. doi: 10.1001/archderm.144.8.1061. Arch Dermatol. 2008. PMID: 18711088 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,245 results

Search Page

Filters